NCT04803656

Brief Summary

The purpose of this research was to examine the respiratory functions, respiratory muscle strength and peripheral muscle strength of patients with COPD in different groups and to evaluate their correlation with the duration and prognosis of the disease in COPD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 8, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2019

Completed
27 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 19, 2019

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

March 9, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 18, 2021

Completed
Last Updated

March 18, 2021

Status Verified

March 1, 2021

Enrollment Period

3 months

First QC Date

March 9, 2021

Last Update Submit

March 16, 2021

Conditions

Keywords

COPDPulmonary functionsRespiratory muscle strengthPeripheral muscle strength

Outcome Measures

Primary Outcomes (4)

  • Respiratory Muscle Strength

    It is a non-invasive test that indirectly demonstrates respiratory muscle strength with maximal inspiratory pressure (PImax) and maximal expiratory pressure (PEmax).Test were carried out according to American Thoracic Society (ATS) / European Respiratory Society (ERS) criteria.

    10 minutes after obtaining socio-demographic information (It was done between the 10th and 20th minutes of the assessment).

  • Peripheral Muscle Strength Assessment-Upper extremity

    Upper extremity: For grip strength test a manual hydraulic dynamometer was used according to the recommendations of the American Association of Hand Therapists (AETD). The patients were measured in sitting position, shoulder adduction at 90 °, elbow flexion, forearm in pronosupination, neutral and wrist joints in neutral position. Three consecutive measurements were obtained by giving 60-second rest breaks between measurements. The result obtained from the average of three measurements was recorded.

    25 minutes after obtaining socio-demographic information. After the respiratory muscle strength evaluation, the patients were rested for 5 minutes (It was done between the 25th and 35th minutes of the assessment).

  • Peripheral Muscle Strength Assessment-Lower extremity

    M. Quadriceps femoris strength was evaluated for knee extension. M. Hamstring strength was evaluated for knee flexion. The test was applied with the "make test" technique that requires isometric contraction. Participant was asked to maintain maximum isometric contraction for 5 seconds, and the average of 3 consecutive maximum contraction measurements performed at 30-second intervals was recorded.

    40 minutes after obtaining socio-demographic information. After Upper extremity muscle strength evaluation patients were rested for five minutes (It was done between the 40th and 55th minutes of the assessment)

  • Pulmonary Function Test (PFT) results

    The PFT results of patients' performed during their routine controls taken into consideration. The percentages of the predicted values (percent) for forced expiratory volume in one second (FEV1), forced vital capacity (FVC), FEV1/FVC, mid-expiratory flow rate (MEF25-75) and peak expiratory flow (PEF) were used for statistical analysis.

    55 minutes after obtaining socio-demographic information.

Secondary Outcomes (3)

  • Duration of the disease

    After the permission of patients, in the first 10 minutes of assessment while obtaining socio-demographic information of patients.

  • Exacerbation numbers in last one year

    After the permission of patients, in the first 10 minutes of assessment while obtaining socio-demographic information of patients.

  • Hospitalization numbers in last one year

    After the permission of patients, in the first 10 minutes of assessment while obtaining socio-demographic information of patients.

Study Arms (1)

Assesment

OTHER

Demographic information of all subjects (age, gender, educational status, occupation, body weight, height, body mass index), clinical (diagnosis period) and medical status, personal history and family history, COPD stage, COPD Assessment Test (CAT) score, emergency and hospital admissions numbers in the last 3 months, exacerbation and hospitalization numbers in the last one year were recorded. Respiratory and peripheral muscle strengths are evaluated. Also pulmonary functions test results obtained.

Other: Assessment of COPD patients

Interventions

Assessments explained in the arm section were made as described in one session.

Assesment

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being in COPD stable period and over the age of 40,
  • The absence of abnormal laboratory findings,
  • Not having a mental problem that prevents filling the questionnaires to be used in the study, - The absence of any other respiratory disease such as asthma,
  • Giving the informed consent.

You may not qualify if:

  • COPD exacerbation (hospitalization with acute exacerbation in the last 15 days),
  • Presence of cognitive impairment,
  • Pregnancy status,
  • Ischemic heart disease,
  • Kyphoscoliosis and advanced postural disorder,
  • Orthopedic problems and amputation surgery,
  • Emphysema, bullous lung disease,
  • Presence of bronchiectasis,
  • Previous thoracic surgery history,
  • Presence of lung cancer,
  • Advanced heart failure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University

Istanbul, Maltepe, 34854, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Begum Unlu, PT, MSc

    Marmara University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: COPD patients: Respiratory muscle strength, peripheral muscle strength in both upper and lower extremity were evaluated. Pulmonary function tests obtained during routine controls of patients.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 9, 2021

First Posted

March 18, 2021

Study Start

February 8, 2019

Primary Completion

May 23, 2019

Study Completion

June 19, 2019

Last Updated

March 18, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations